Literature DB >> 12842890

The roles of Cbl-b and c-Cbl in insulin-stimulated glucose transport.

Jun Liu1, Stephanie M DeYoung, Joseph B Hwang, Erin E O'Leary, Alan R Saltiel.   

Abstract

Previous studies suggest that the stimulation of glucose transport by insulin involves the tyrosine phosphorylation of c-Cbl and the translocation of the c-Cbl/CAP complex to lipid raft subdomains of the plasma membrane. We now demonstrate that Cbl-b also undergoes tyrosine phosphorylation and membrane translocation in response to insulin in 3T3-L1 adipocytes. Ectopic expression of APS facilitated insulin-stimulated phosphorylation of tyrosines 665 and 709 in Cbl-b. The phosphorylation of APS produced by insulin drove the translocation of both c-Cbl and Cbl-b to the plasma membrane. Like c-Cbl, Cbl-b associates constitutively with CAP and interacts with Crk upon insulin stimulation. Cbl proteins formed homo- and heterodimers in vivo, which required the participation of a conserved leucine zipper domain. A Cbl mutant incapable of dimerization failed to interact with APS and to undergo tyrosine phosphorylation in response to insulin, indicating an essential role of Cbl dimerization in these processes. Thus, both c-Cbl and Cbl-b can initiate a phosphatidylinositol 3-kinase/protein kinase B-independent signaling pathway critical to insulin-stimulated GLUT4 translocation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12842890     DOI: 10.1074/jbc.M300664200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

Review 1.  Transgenic mouse models resistant to diet-induced metabolic disease: is energy balance the key?

Authors:  Laura A A Gilliam; P Darrell Neufer
Journal:  J Pharmacol Exp Ther       Date:  2012-06-13       Impact factor: 4.030

2.  Neuronal Cbl controls biosynthesis of insulin-like peptides in Drosophila melanogaster.

Authors:  Yue Yu; Ying Sun; Shengqi He; Cheng Yan; Liangyou Rui; Wenjun Li; Yong Liu
Journal:  Mol Cell Biol       Date:  2012-07-09       Impact factor: 4.272

3.  Oncogenic Signaling by Leukemia-Associated Mutant Cbl Proteins.

Authors:  Scott Nadeau; Wei An; Nick Palermo; Dan Feng; Gulzar Ahmad; Lin Dong; Gloria E O Borgstahl; Amarnath Natarajan; Mayumi Naramura; Vimla Band; Hamid Band
Journal:  Biochem Anal Biochem       Date:  2012-07-30

4.  Identification of SH2B2beta as an inhibitor for SH2B1- and SH2B2alpha-promoted Janus kinase-2 activation and insulin signaling.

Authors:  Minghua Li; Zhiqin Li; David L Morris; Liangyou Rui
Journal:  Endocrinology       Date:  2007-01-04       Impact factor: 4.736

Review 5.  "Actin"g on GLUT4: membrane & cytoskeletal components of insulin action.

Authors:  Joseph T Brozinick; Bradley A Berkemeier; Jeffrey S Elmendorf
Journal:  Curr Diabetes Rev       Date:  2007-05

Review 6.  Roles of E3 ubiquitin ligases in cell adhesion and migration.

Authors:  Cai Huang
Journal:  Cell Adh Migr       Date:  2010-01-18       Impact factor: 3.405

Review 7.  SH2B1 regulation of energy balance, body weight, and glucose metabolism.

Authors:  Liangyou Rui
Journal:  World J Diabetes       Date:  2014-08-15

8.  Disruption of cortical actin in skeletal muscle demonstrates an essential role of the cytoskeleton in glucose transporter 4 translocation in insulin-sensitive tissues.

Authors:  Joseph T Brozinick; Eric D Hawkins; Andrew B Strawbridge; Jeffrey S Elmendorf
Journal:  J Biol Chem       Date:  2004-07-06       Impact factor: 5.157

9.  Disruption of the SH2-B gene causes age-dependent insulin resistance and glucose intolerance.

Authors:  Chaojun Duan; Hongyan Yang; Morris F White; Liangyou Rui
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

10.  Activation of atypical protein kinase Czeta toward TC10 is regulated by high-fat diet and aerobic exercise in skeletal muscle.

Authors:  Misato Saito; S J Lessard; Donato A Rivas; Donald W Reeder; John A Hawley; Ben B Yaspelkis
Journal:  Metabolism       Date:  2008-09       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.